Target intelligence / Profile preview

MicroRNA 4698 (miR-4698)

Target
miR-4698
Molecular classification
microRNA (miRNA), Non-coding RNA
01

Overview

MicroRNA 4698 is a small, non-coding RNA molecule (20–24 nucleotides) classified as a microRNA. It functions primarily as a post-transcriptional regulator by binding to complementary sequences in the 3′ untranslated region (UTR) of target mRNAs, thereby leading to mRNA degradation or inhibition of translation. miR-4698 is encoded on chromosome 12 and has demonstrated activity as a tumor suppressor in glioblastoma cell lines, inhibiting cell proliferation and targeting the PI3K/AKT signaling pathway, including genes such as PI3KCA, PI3KCB, PDK1, AKT1, Rheb, MDM2, mTOR, and CREB1. Expression studies indicate its downregulation in certain cancers (glioblastoma, conjunctival cancer, gastric cancer stem cells) and in COPD. It is a promising molecule for gene therapy and as a biomarker for disease diagnosis and progression.

Other names
MIR4698miR-4698hsa-mir-4698hsa-miR-4698
02

Mechanism of action

Inhibition of miR-4698 (if upregulated in disease) or overexpression (if downregulated) as a gene therapy strategy. miR-4698 itself suppresses gene expression by binding to the 3′ UTR of target mRNAs, leading to reduced protein levels via mRNA destabilization and translational inhibition.

03

Biological functions

Post-transcriptional gene regulation (miRNAs generally regulate messenger RNA stability and translation)Tumor suppression: Inhibits proliferation and colony formation in glioblastoma cell lines by regulating PI3K/AKT pathway genesInduction of cell cycle arrestPossible regulation of apoptosis
04

Disease associations

Cancer (notably glioblastoma, conjunctival cancer, and possibly gastric cancer stem cells)Chronic obstructive pulmonary disease (COPD)Other diseases may be implicated in future studies based on broader miRNA functions
05

Safety considerations

Delivery of miRNA mimics or inhibitors is an ongoing therapeutic challenge for all microRNAs, including miR-4698; risks include off-target effects, immune response, and incomplete targetingTherapeutic modulation of miRNAs could affect multiple genes and pathways, with unpredictable pleiotropic effects
06

Biomarkers

Serum levels of miR-4698 may be used as biomarkers for glioblastoma and possibly other cancers, as lower expression has been associated with the diseaseDownregulation detected in COPD lung tissues suggests potential for use as a biomarker in respiratory disorders

Beyond the preview

Go deeper on MicroRNA 4698 (miR-4698).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4698 (miR-4698).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call